Cargando…
Bile metabolites as diagnostic biomarkers for perihilar cholangiocarcinoma
It is difficult to directly obtain pathological diagnosis of perihilar cholangiocarcinoma (pCCA). Analysis of bile in the pCCA microenvironment, based on metabolomics and statistical methods, can help in clinical diagnosis. Clinical information, bile samples, blood liver function, blood CA199, CEA,...
Autores principales: | Zhang, DengYong, Zhao, GuanRu, Sun, Wanliang, Wang, Dongdong, Zhou, Shuo, Liu, Zhong, Lu, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950048/ https://www.ncbi.nlm.nih.gov/pubmed/36823159 http://dx.doi.org/10.1038/s41598-023-27603-6 |
Ejemplares similares
-
Influencing factors of biliary fistula after radical resection of hilar cholangiocarcinoma: a prospect cohort
por: Zhang, Dengyong, et al.
Publicado: (2022) -
Application of mesohepatectomy with caudate lobectomy for the treatment of type III–IV hilar cholangiocarcinoma: a single-center retrospective study
por: Wang, Dongdong, et al.
Publicado: (2023) -
Galanin System in the Human Bile Duct and Perihilar Cholangiocarcinoma
por: Huber, Sara, et al.
Publicado: (2023) -
Bacterial bile duct colonization in perihilar cholangiocarcinoma and its clinical significance
por: Bednarsch, Jan, et al.
Publicado: (2021) -
ZFAND5 Is an Independent Prognostic Biomarker of Perihilar Cholangiocarcinoma
por: Liu, Pei, et al.
Publicado: (2022)